Meta-analysis and Trial Sequential Analysis of Therapeutic Efficacy of Modified Cangfu Daotan Decoction Combined with Chemical Medicine versus Chemical Medicine Alone in the Treatment of Polycystic Ovarian Syndrome
- VernacularTitle:加减苍附导痰汤联合化学药对比单用化学药治疗多囊卵巢综合征疗效的Meta分析及试验序贯分析
- Author:
Pengpeng XIE
1
,
2
;
Yizi XIE
1
;
Shuliang JI
1
;
Weipeng SUN
1
;
Zhizhong SUN
1
;
Yueyi REN
1
;
Lei ZENG
3
Author Information
1. The First Clinical College,Guangzhou University of TCM,Guangzhou 510405,China
2. Gynecology Dept. of TCM,Guangzhou Women and Children’s Medical Center,Guangzhou 510405,China
3. Office of Gynecological Department,the First Affiliated Hospital of Gu angzhou University of TCM,Guangzhou 510405,China
- Publication Type:Journal Article
- Keywords:
Polycystic ovarian syndrome;
Chemical medicine;
Modified Cangfu daotan decoction;
Therapeutic efficacy;
Meta-analysis;
Trial sequential analysis
- From:
China Pharmacy
2019;30(5):698-703
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE: To systematically evaluate therapeutic efficacy of modified Cangfu daotan decoction (MCDD) combined with chemical medicine versus chemical medicine alone in the treatment of polycystic ovarian syndrome (PCOS), and to provide evidence-based reference for clinical decision. METHODS: Retrieved from PubMed, Embase, Cochrane Library, CJFD, Wanfang database, VIP and CBM, randomized controlled trials (RCTs) about MCDD combined with chemical medicine [ethynestradiol cycloprogesterone (Diane-35), clomiphene, metformin] (trial group) versus chemical medicine alone (control group) in the treatment of PCOS were collected. After data extraction and quality evaluation with Cochrane 5.1.0 bias risk evaluation tool and Jadad scale, Meta-analysis was conducted for total response rate, serum hormone level (FSH, LH, LH/FSH, testosterone), BMI, ovulation rate and physical signs (hirsutism, acne) by using Stata 14.0 software. Trial sequential analysis(TSA)was conducted by using TSA 0.9 software. RESULTS: A total of 20 RCTs were included, involving 1 484 patients. Results of Meta analysis showed that total response rate [RR=1.13,95%CI (1.02,1.24),P<0.05], serum hormone level {FSH [WMD=-0.59,95%CI(-0.98,-0.20),P<0.05],LH [WMD=-0.95,95%CI(-1.41, -0.52),P<0.05],LH/FSH [WMD=-1.04,95%CI(-1.78,-0.33),P<0.05],testosterone [WMD=-0.93,95%CI(-1.38,-0.28),P<0.05]}, BMI [SMD=-1.01,95%CI (-1.76,-0.27),P<0.05], ovulation rate [RR=1.17,95%CI(1.02,1.34),P<0.05] and physical signs {hirsutism [WMD=-0.48,95%CI(-0.86, -0.10),P<0.05], acne [WMD=-1.16,95%CI(-1.56,-0.75),P<0.05]} of trial group were all better than those of control group, with statistical significance. TSA showed that there are reliable evidences for MCDD combined with chemical medicine in the treatment of PCOS. CONCLUSIONS: Versus chemical medicine alone in the treatment of PCOS, MCDD combined with chemical medicine can improve total response rate and ovulation rate, reduce serum hormone levels, BMI and physical signs.